학술논문

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Document Type
article
Author
Matuozzo, DanielaTalouarn, EstelleMarchal, AstridZhang, PengManry, JeremySeeleuthner, YoannZhang, YuBolze, AlexandreChaldebas, MatthieuMilisavljevic, BaptisteGervais, AdrianBastard, PaulAsano, TakakiBizien, LucyBarzaghi, FedericaAbolhassani, HassanAbou Tayoun, AhmadAiuti, AlessandroAlavi Darazam, IladAllende, Luis MAlonso-Arias, RebecaArias, Andrés AugustoAytekin, GokhanBergman, PeterBondesan, SimoneBryceson, Yenan TBustos, Ingrid GCabrera-Marante, OscarCarcel, SheilaCarrera, PaolaCasari, GiorgioChaïbi, KhalilColobran, RogerCondino-Neto, AntonioCovill, Laura EDelmonte, Ottavia MEl Zein, LoubnaFlores, CarlosGregersen, Peter KGut, MartaHaerynck, FilomeenHalwani, RabihHancerli, SeldaHammarström, LennartHatipoğlu, NevinKarbuz, AdemKeles, SevgiKyheng, ChristèleLeon-Lopez, RafaelFranco, Jose LuisMansouri, DavoodMartinez-Picado, JavierMetin Akcan, OzgeMigeotte, IsabelleMorange, Pierre-EmmanuelMorelle, GuillaumeMartin-Nalda, AndreaNovelli, GiuseppeNovelli, AntonioOzcelik, TayfunPalabiyik, FigenPan-Hammarström, Qiangde Diego, Rebeca PérezPlanas-Serra, LauraPleguezuelo, Daniel EPrando, CarolinaPujol, AuroraReyes, Luis FelipeRivière, Jacques GRodriguez-Gallego, CarlosRojas, JulianRovere-Querini, PatriziaSchlüter, AgathaShahrooei, MohammadSobh, AliSoler-Palacin, PereTandjaoui-Lambiotte, YacineTipu, ImranTresoldi, CristinaTroya, Jesusvan de Beek, DiederikZatz, MayanaZawadzki, PawelAl-Muhsen, Saleh ZaidAlosaimi, Mohammed FarajAlsohime, Fahad MBaris-Feldman, HagitButte, Manish JConstantinescu, Stefan NCooper, Megan ADalgard, Clifton LFellay, JacquesHeath, James RLau, Yu-LungLifton, Richard PManiatis, TomMogensen, Trine Hvon Bernuth, HorstLermine, AlbanVidaud, Michel
Source
Genome Medicine. 15(1)
Subject
Clinical Research
Infectious Diseases
Pneumonia & Influenza
Genetics
Human Genome
Prevention
2.1 Biological and endogenous factors
Aetiology
Humans
Young Adult
Adult
Middle Aged
COVID-19
SARS-CoV-2
Toll-Like Receptor 3
Toll-Like Receptor 7
Interferon Type I
Autoantibodies
COVID Human Genetic Effort
COVIDeF Study Group
French COVID Cohort Study Group
CoV-Contact Cohort
COVID-STORM Clinicians
COVID Clinicians
Orchestra Working Group
Amsterdam UMC Covid-19 Biobank
NIAID-USUHS COVID Study Group
Immunity
Rare variants
Type I interferon
Clinical Sciences
Language
Abstract
BackgroundWe previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15-20% of cases of life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants of life-threatening COVID-19 remain to be identified in ~ 80% of cases.MethodsWe report here a genome-wide rare variant burden association analysis in 3269 unvaccinated patients with life-threatening COVID-19, and 1373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. Among the 928 patients tested for autoantibodies against type I IFN, a quarter (234) were positive and were excluded.ResultsNo gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants was TLR7, with an OR of 27.68 (95%CI 1.5-528.7, P = 1.1 × 10-4) for biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR = 3.70[95%CI 1.3-8.2], P = 2.1 × 10-4). This enrichment was further strengthened by (1) adding the recently reported TYK2 and TLR7 COVID-19 loci, particularly under a recessive model (OR = 19.65[95%CI 2.1-2635.4], P = 3.4 × 10-3), and (2) considering as pLOF branchpoint variants with potentially strong impacts on splicing among the 15 loci (OR = 4.40[9%CI 2.3-8.4], P = 7.7 × 10-8). Finally, the patients with pLOF/bLOF variants at these 15 loci were significantly younger (mean age [SD] = 43.3 [20.3] years) than the other patients (56.0 [17.3] years; P = 1.68 × 10-5).ConclusionsRare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60 years old.